Table 2 Histologic characteristics of HBV-infected patients with and without hepatic steatosis
|  | HBV infection (N = 616) | HBV infection + NAFLD (N = 255) | P value |
|---|---|---|---|
Steatosis |  |  | < 0.001 |
0 | 616 (100%) | 0 | |
1 | 0 | 219 (85.88%) | |
2 | 0 | 33 (12.94%) | |
3 | 0 | 3 (1.18%) | |
Lobular inflammation | Â | Â | 0.323 |
0 | 1 (0.16%) | 0 | |
1 | 389 (63.15%) | 150 (58.82%) | |
2 | 210 (34.09%) | 93 (36.47%) | |
3 | 15 (2.44%) | 12 (4.71%) | |
4 | 1 (0.16%) | 0 | |
Portal inflammation |  |  | < 0.001 |
1 | 360 (58.44%) | 101 (39.61%) | |
2 | 227 (36.85%) | 127 (49.80%) | |
3 | 26 (4.22%) | 26 (10.20%) | |
4 | 3 (0.49%) | 1 (0.39%) | |
Hepatic ballooning | Â | Â | Â |
0 | 608 (98.70%) | 239 (93.73%) | Â |
1 | 8 (1.30%) | 9 (3.53%) | < 0.001 |
2 | 0 | 7 (2.75%) | Â |
3 | 0 | 0 | Â |
G |  |  | < 0.001 |
1 | 318 (51.62%) | 92 (36.08%) | |
2 | 268 (43.51%) | 135 (52.94%) | |
3 | 28 (4.55%) | 27 (10.59%) | |
4 | 2 (0.32%) | 1 (0.39%) | |
S | Â | Â | 0.071 |
0 | 11 (1.79%) | 0 | |
1 | 236 (38.31%) | 97 (38.04%) | |
2 | 259 (42.05%) | 97 (38.04%) | |
3 | 54 (8.77%) | 30 (11.76%) | |
4 | 56 (9.09%) | 31 (12.16%) | |
Significant liver fibrosis | 369 (59.90%) | 158 (61.96%) | 0.572 |
Advanced liver fibrosis | 110 (17.857%) | 61 (23.922%) | 0.049 |
Significant liver inflammation | 298 (48.38%) | 163 (63.92%) | < 0.001 |